NCT07028645View on ClinicalTrials.gov

Uroflowmetry and Nocturnal Enuresis

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 20, 2022

Primary Completion Date

September 1, 2024

Study Completion Date

December 30, 2025

Conditions
Enuresis, Nocturnal
Interventions
DRUG

desmopressin melt form 120 μg

Desmopressin 120 mcg will be used frist-line drug in the treatment of enuresis.

DRUG

Desmopressin lyophilisate (Melt)

Desmopressin 240 mcg will be used for the patients who have not responsive to desmopressin 120 mcg.

DRUG

Propiverine tablet

Propiverine (a dose of 0.8 mg/ kg) will be used for the patients who have -response to treatment with desmopressin 240 mcg

Trial Locations (1)

34000

Sancaktepe Sehit Prof dr Ilhan Varank Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Furkan Adem Canbaz

OTHER